A. John Camm
St. George's Hospital Medical School
University of London
Cranmer Terrace
London SW17 0RE
UK
Name/email consistency: high
- Clinical trial design to evaluate the effects of drugs on cardiac repolarization: current state of the art. Camm, A.J. Heart. Rhythm (2005)
- Mortality in patients after a recent myocardial infarction: a randomized, placebo-controlled trial of azimilide using heart rate variability for risk stratification. Camm, A.J., Pratt, C.M., Schwartz, P.J., Al-Khalidi, H.R., Spyt, M.J., Holroyde, M.J., Karam, R., Sonnenblick, E.H., Brum, J.M. Circulation (2004)
- Advances in antiarrhythmic drug treatment of atrial fibrillation: where do we stand now?. Camm, A.J., Savelieva, I. Heart. Rhythm (2004)
- Electrophysiological effects of a single intravenous administration of ivabradine (S 16257) in adult patients with normal baseline electrophysiology. Camm, A.J., Lau, C.P. Drugs. R. D (2003)
- Translation of clinical trials into clinical practice: use of results in formulating guidelines. Camm, A.J. J. Cardiovasc. Electrophysiol. (2003)
- Rationale and patient selection for "hybrid" drug and device therapy in atrial and ventricular arrhythmias. Camm, A.J., Savelieva, I. J. Interv. Card. Electrophysiol (2003)
- The design and conduct of human studies to detect and quantify QT interval prolongation induced by new chemical entities. Camm, A.J. Fundam. Clin. Pharmacol (2002)
- Rate versus rhythm control: is the debate over?. Camm, A.J., Savelieva, I. J. Interv. Card. Electrophysiol (2002)
- What should we expect from the next generation of antiarrhythmic drugs?. Camm, A.J., Yap, Y.G. J. Cardiovasc. Electrophysiol. (1999)
